What If I Get Another Clot on Warfarin With INR in Range?

Developing a new blood clot while your INR is in the target range is a serious event that requires urgent medical attention, but it does not automatically mean your medication has failed. For patients living with familial antiphospholipid syndrome (APS), confirming the clot and identifying its cause is a careful step-by-step process. First, emergency assessment is needed to rule out life-threatening complications ^[1]. Once a new clot is confirmed and stabilized, your specialist will investigate whether your INR readings were accurate and whether there were hidden triggers, like infections ^{[2] [3]}. If it is a true breakthrough clot, specialists will individualize your treatment based on guidelines—options include adding low-dose aspirin, increasing your target INR, or switching to an injectable blood thinner like low-molecular-weight heparin ^[4]. Never adjust your warfarin dose or add aspirin on your own, as this can dangerously increase your risk of severe bleeding.

1. Seek Urgent Medical Care

Any new symptoms of a blood clot require emergency assessment. Call emergency services or go to the nearest emergency room immediately if you experience:

• Severe, sudden shortness of breath or chest pain (signs of a pulmonary embolism, or a clot in the lungs)
• Sudden weakness, facial drooping, or difficulty speaking (signs of a stroke)
• A cold, pale, and painful arm or leg (signs of acute limb ischemia, a severe arterial blockage)
• Sudden, severe leg swelling and pain (signs of a deep vein thrombosis or DVT)

Do not wait for a routine appointment, and do not stop or double your warfarin dose unless instructed by the emergency medical team.

In the emergency room, clinicians will use specific imaging tests based on your symptoms—such as a CT scan for the lungs, or a compression ultrasound for the legs—to confirm if a clot is truly new ^[1]. Sometimes, symptoms are caused by residual damage from an old clot, so they will compare the new scans to your previous ones. They will also ensure you are not experiencing a rare, rapidly progressive complication called catastrophic antiphospholipid syndrome (CAPS), which involves clots in multiple organs and severe illness ^[5]. (CAPS is very rare, and a single recurrent clot does not usually mean you have it).

2. Investigating the Cause: Is it a True Warfarin Failure?

Before changing your long-term treatment plan, your hematology or rheumatology team will investigate why the clot happened.

• INR Accuracy and Antibody Interference: In some APS patients, a core antibody called the lupus anticoagulant can interfere with the chemicals used to test the INR, especially in finger-prick (point-of-care) machines ^[6]. This interference can make your INR look artificially high, meaning the test overestimates the actual anticoagulant effect ^[3]. If your team suspects this, they may compare it to a laboratory blood draw or use an alternative test called a chromogenic factor X assay to get an accurate measurement ^{[7] [8]}.
• Time in Therapeutic Range (TTR): TTR is the percentage of time your INR stays within your target range. Your team will look at your history over the past months; a single in-range INR reading does not guarantee you have been consistently protected ^[9].
• Diet and Medication Changes: Starting or stopping medications (like antibiotics) or making drastic changes to your diet can cause rapid shifts in your INR ^[9]. The goal with diet is to keep your vitamin K intake (like leafy greens) consistent, rather than avoiding it entirely.
• New Triggers: While APS clots can happen without any identifiable trigger, doctors will look for recent infections, surgeries, periods of immobility, or flares of another autoimmune disease (like systemic lupus erythematosus (SLE)), which can temporarily increase clotting risk ^{[2] [10]}.

3. Adjusting Your Treatment Plan

If the clot is confirmed as a true breakthrough event while you were adequately treated, your specialist will tailor a new strategy. There is no single “best” path for everyone. The choice depends on whether your clot was venous (in a vein, like a DVT) or arterial (in an artery, like a stroke), and balancing that against your risk of major bleeding ^[4]. Guideline-supported options include:

• Adding Low-Dose Aspirin: Combining warfarin with a low-dose aspirin can provide extra protection, but this is generally considered more for arterial clots and carries a higher bleeding risk ^{[4] [11]}.
• Increasing the INR Target: Your doctor may increase your target INR range to 3.0–4.0 ^[12]. However, clinical trials have not consistently proven that higher-intensity warfarin is better than standard-intensity for all APS patients, and it does increase the risk of bleeding ^[13].
• Switching to Low-Molecular-Weight Heparin (LMWH): This involves switching from oral warfarin to once- or twice-daily injections under the skin ^[4].

(Note: In rare, refractory cases, specialists might consider other off-label injectable medications like fondaparinux, but this is not standard therapy ^[14].)

Because these escalations can increase your bleeding risk, you must watch for bleeding red flags—such as uncontrollable bleeding, black or tarry stools, vomiting blood, or severe sudden headaches—and seek immediate help if they occur.

What About DOACs?

Direct oral anticoagulants (DOACs), such as rivaroxaban or apixaban, are popular alternatives to warfarin for the general public. However, they are not recommended as a fallback option for recurrent APS clots ^[4]. Clinical trials have shown a higher rate of arterial clots when DOACs are used in high-risk APS patients (those who have had arterial clots or who test positive for all three APS antibodies, known as “triple-positive”) ^{[15] [16]}. Do not switch to a DOAC without direct consultation with an APS specialist.